HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amino acid utilization during apoptosis in HL-60 cells.

Abstract
Human promyelocytic leukemia (HL-60), human squamous carcinoma (HSC-2, HSC-4, NA) and rat pheochromocytoma (PC-12) cell lines consumed nonpolar (Leu, Ile, Val, Cys, Met, Phe), neutral polar (Gln, Ser, Thr, Tyr) and basic polar amino acids (Arg, Lys, His), whereas they produced nonpolar (Gly, Pro, Ala) and acidic polar amino acids (Glu). The consumption rate of Ser and Arg by HL-60 cells was significantly higher than that of other cell lines. During apoptosis of HL-60 cells induced by either sodium ascorbate, sodium 5,6-benzylidene-L-ascorbate (SBA) or dopamine, the consumption of nonpolar and polar amino acids (neutral or acidic) generally declined, except for Cys, Met and Arg, whereas the production of Gly and Glu was slightly increased. Since the intracellular concentration of cGMP was not significantly changed before and after ascorbate treatment, nitric oxide might not be involved in the ascorbate-induced apoptosis. The present data demonstrates that consumption rate of nonpolar and polar amino acid, whether neutral, acidic or basic, was reduced almost evenly during the apoptosis induction. This suggests that apoptosis-associated changes in the amino acid utilization might not be significantly affected by ATP depletion, which might be caused by mitochondrial dysfunction.
AuthorsH Sakagami, Y Yokote, M Kochi, E Hara, K Akahane
JournalAnticancer research (Anticancer Res) 1999 Jan-Feb Vol. 19 Issue 1A Pg. 329-32 ISSN: 0250-7005 [Print] Greece
PMID10226562 (Publication Type: Journal Article)
Chemical References
  • Amino Acids
  • Adenosine Triphosphate
Topics
  • Adenosine Triphosphate (metabolism)
  • Amino Acids (metabolism)
  • Animals
  • Apoptosis
  • HL-60 Cells
  • Humans
  • PC12 Cells
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: